Enabling faster execution and on-time delivery in a complex, global vaccine trial.

When one sponsor needed to build efficiencies into their processes to meet their aggressive FPI timelines for their international Phase III vaccine trials, they partnered with Thermo Fisher Scientific to leverage Accelerator™ Drug Development.

Explore the outcomes of this partnership with key takeaways and lessons learned from this case study.

Download the case study to learn more about:

  • The challenges of a global vaccine clinical trial spanning 6K patients, 170 sites, and 20 countries
  • Strategies for overcoming cold-chain supply, FPI, and labeling challenges
  • The impacts of enabling early ID testing by aligning quality agreement parameters
  • Approaches used to achieve significant time savings on IMP release
  • Post-trial benefits: How Thermo Fisher and the sponsor created a scalable model for future trials
Name
Checkboxes

© 2025 MarketingMastersHub.com. All rights reserved.